🇺🇸 FDA
Patent

US 6706686

Inhibition of histone deacetylase as a treatment for cardiac hypertrophy

expired A61KA61K31/165A61K31/19

Quick answer

US patent 6706686 (Inhibition of histone deacetylase as a treatment for cardiac hypertrophy) held by The Regents of the University of Colorado expires Mon Mar 11 2024 00:00:00 GMT+0000 (Coordinated Universal Time). Status: expired.

Key facts

Applicant
The Regents of the University of Colorado
Grant date
Tue Mar 16 2004 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon Mar 11 2024 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
50
CPC classes
A61K, A61K31/165, A61K31/19, A61K31/401, A61K38/12